BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Ablynx’s Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (The “Transparency Law”)

  Ablynx received a notification of shareholdings from Consonance CapMan GP LLC on 11 October 2017.

  October 16, 2017

   · 

  4 min read
• Drug Development

  New Published Data Highlights the Potential of Pluristem’s PLX Cells in Improving Cardiac Function in Diabetes

  The results of the preclinical study is published in the peer-reviewed journal STEM CELLS Translational Medicine.

  October 16, 2017

   · 

  6 min read
• Deals

  Teijin Acquires Exclusive Sales Rights To Transcranial Magnetic Stimulation Device In Japan

  Teijin Pharma Limited announced today that it has acquired the exclusive sales rights in Japan to the NeuroStar Transcranial Magnetic Stimulation (TMS) for treating depression that does not respond well to normal antidepressant drug-based therapies.

  October 16, 2017

   · 

  2 min read
• Business

  Lilly Declares Fourth-Quarter 2017 Dividend

  The board of directors of Eli Lilly has declared a dividend for the fourth quarter of 2017 of $0.52 per share on outstanding common stock.

  October 16, 2017

   · 

  1 min read
• Business

  Cerveau Technologies Signs Collaboration Agreement With Janssen For Novel Tau Imaging Agent

  Cerveau Technologies today announced a research collaboration agreement with Janssen Pharmaceuticals, Inc. for use of [F-18]MK-6240.

  October 16, 2017

   · 

  1 min read
• A*STAR Release: Scientists Uncover A New Layer Of Complexity Beyond The Human Genome

  Singaporean researchers have made significant inroads in the study of Ribonucleic Acid (RNA) editing.

  October 16, 2017

   · 

  4 min read
• Drug Development

  BioAegis Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase II Clinical Trials in Community-Acquired Pneumonia

  Dr. DiNubile brings to BioAegis the rare combination of clinical and research expertise along with broad pharmaceutical industry experience.

  October 16, 2017

   · 

  3 min read
• Business

  Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation

  Medtronic and Mercy together will establish a new data sharing and analysis network that helps gather clinical evidence for medical device innovation and patient access.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Cara Therapeutics Announces Successful End-of-Phase II Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus

  Cara, in consultation with the FDA, has established the key elements of the Phase 3 program to support a New Drug Application (NDA) for I.V. CR845.

  October 16, 2017

   · 

  5 min read
• Orthocell Granted Celgro Patent Protection In Canada

  Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.

  October 16, 2017

   · 

  3 min read